Biogen (BIIB) Reports Q4 Adj-EPS of $1.20, Beats by 15c; Guides FY10 Above the Street
Tweet Send to a Friend
Biogen Idec Inc. (NASDAQ: BIIB) reports Q4 EPS of $1.20, ex-items ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
